Helene Hallböök, Magnus Björkholm, Hans Hägglund, Bengt Smedmyr. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultAgedFemaleFollow-Up StudiesGranulocyte Colony-Stimulating Factor/administration & dosageGranulocyte Colony-Stimulating Factor/geneticsGranulocyte Colony-Stimulating Factor/therapeutic useHumansInjections, SubcutaneousKaplan-Meier EstimateMaleMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/pathologyProspective StudiesRecombinant Proteins/administration & dosageRecombinant Proteins/therapeutic useTime FactorsTreatment OutcomeYoung Adult
Substances: See more » Recombinant ProteinsGranulocyte Colony-Stimulating Factor
Year: 2009 PMID: 19883315 DOI: 10.3109/10428190903150821
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022